Point72 Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-29,220
Closed -$806K 2198
2023
Q4
$806K Buy
29,220
+28,762
+6,280% +$1.75M ﹤0.01% 1463
2023
Q3
$27.8K Buy
458
+453
+9,060% +$31.8K ﹤0.01% 2246
2023
Q2
$355 Sell
5
-44,280
-100% -$3.24M ﹤0.01% 2033
2023
Q1
$2.82M Sell
44,285
-16,119
-27% -$1.84M 0.01% 920
2022
Q4
$8.36M Buy
+60,404
New +$8.51M 0.03% 606
2022
Q3
Sell
-40,765
Closed -$3.38M 1418
2022
Q2
$3.38M Buy
+40,765
New +$3.16M 0.01% 804
2021
Q3
Sell
-43,494
Closed -$18M 1047
2021
Q2
$18M Buy
+43,494
New +$17.2M 0.08% 306
2018
Q4
Sell
-1,158
Closed -$2.19M 970
2018
Q3
$2.19M Sell
1,158
-1,351
-54% -$2.79M 0.01% 751
2018
Q2
$5.1M Buy
2,509
+2,123
+550% +$4.84M 0.02% 599
2018
Q1
$854K Sell
386
-5,072
-93% -$12.9M ﹤0.01% 829
2017
Q4
$12.6M Buy
+5,458
New +$11.1M 0.05% 401
2017
Q1
Sell
-7,430
Closed -$5.94M 818
2016
Q4
$5.94M Buy
+7,430
New +$5.9M 0.04% 419
2015
Q4
Sell
-17,988
Closed -$19.9M 686
2015
Q3
$19.9M Buy
17,988
+2,000
+13% +$3.65M 0.16% 194
2015
Q2
$34.9M Buy
+15,988
New +$32.6M 0.24% 120
2015
Q1
Sell
-3,435
Closed -$4.08M 686
2014
Q4
$4.08M Sell
3,435
-42,491
-93% -$28.4M 0.03% 467
2014
Q3
$21.3M Buy
45,926
+7,990
+21% +$3.69M 0.16% 172
2014
Q2
$19M Buy
+37,936
New +$12.2M 0.12% 217

Other funds holding BLUE

Point72 Asset Management's BLUE Position: Q1 2024 in Review

Point72 Asset Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 29,220 shares — an estimated $806K sold.

Point72 Asset Management first reported a position in BLUE in Q2 2014 and held it in 17 quarters. The position peaked at $34.9M in Q2 2015. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Point72 Asset Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Point72 Asset Management sold 29,220 bluebird bio shares in Q1 2024, an estimated $806K.
  • Point72 Asset Management first reported a position in bluebird bio in Q2 2014 and held it in 17 quarters.
  • Point72 Asset Management's bluebird bio position peaked at $34.9M in Q2 2015.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.